Controlled Substances Act (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Controlled Substances Act" in German language version.

refsWebsite
Global rank German rank
1st place
1st place
33rd place
2nd place
332nd place
705th place
2nd place
3rd place
4th place
7th place
447th place
751st place
730th place
1,066th place
low place
low place
3rd place
67th place
918th place
2,263rd place
2,474th place
5,080th place
6,166th place
low place
low place
low place
1,115th place
2,038th place
low place
low place
low place
low place
7,652nd place
low place
low place
low place
low place
low place
27th place
106th place
218th place
968th place
696th place
1,897th place
1,360th place
2,440th place
2,755th place
low place
low place
7,024th place

books.google.com

  • Strength of the Pack: The Personalities, Politics and Espionage Intrigues. Douglas Valentine, 2010, ISBN 978-1-936296-91-0 (Google Books [abgerufen am 13. Mai 2018]).
  • Richard R. Abood: Pharmacy Practice and the Law. Jones & Bartlett, 2012, ISBN 978-1-4496-8691-8, The Closed System of Controlled Substance Distribution, S. 184 (Google Books [abgerufen am 30. Dezember 2012]).

cdc.gov

congress.gov

cornell.edu

law.cornell.edu

www4.law.cornell.edu

doi.org

  • David T. Courtwright: The Controlled Substances Act: how a „big tent“ reform became a punitive drug law. In: Drug and Alcohol Dependence. Band 76, Nr. 1, 5. Oktober 2004, S. 9–15, doi:10.1016/j.drugalcdep.2004.04.012, PMID 15380284.
  • Paul Gee, Mark Gilbert, Sandra Richardson, Grant Moore, Sharon Paterson, Patrick Graham: Toxicity from the Recreational Use of 1-benzylpiperazine. In: Clinical Toxicology. Band 46, Nr. 9, 2008, S. 802–07, doi:10.1080/15563650802307602, PMID 18821145.
  • K. Brennan, A. Johnstone, P. Fitzmaurice, R. Lea, S. Schenk: Chronic Benzylpiperazine (BZP) Exposure Produces Behavioral Sensitization and Cross-sensitization to Methamphetamine (MA). In: Drug and Alcohol Dependence. Band 88, Nr. 2–3, 2007, S. 204–13, doi:10.1016/j.drugalcdep.2006.10.016, PMID 17125936.
  • G. Tunnicliff: Sites of action of gamma hydroxybutyrate (GHB) – A neuroactive drug with abuse potential. In: Clinical Toxicology. Band 35, Nr. 6, 1997, S. 581–590, doi:10.3109/15563659709001236.
  • J.H. Halpern: Hallucinogens and dissociative agents naturally growing in the United States. In: Pharmacology & Therapeutics. Band 102, Nr. 2, 2004, S. 131–138, doi:10.1016/j.pharmthera.2004.03.003, PMID 15163594.
  • David J. Nutt, Leslie A. King, Lawrence D. Phillips Independent Scientific Committee on Drugs: Drug harms in the UK: A multicriteria decision analysis. In: The Lancet. Band 376, Nr. 9752, 6. November 2010, S. 1558–1565, doi:10.1016/S0140-6736(10)61462-6, PMID 21036393.

drugabuse.gov

druglibrary.net

  • Rufus King: The Drug Hang Up, America's Fifty-Year Folly. Schaffer Library of Drug Policy, The 1970 Act: Don't Sit There, Amend Something (Online).

druglibrary.org

fda.gov

federalregister.gov

  • Drug Enforcement Administration: Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine Into Schedule I of the Controlled Substances Act. In: Federal Register. Band 74, Nr. 161, 21. August 2009, S. 42217–42220: „Under the authority vested in the Attorney General by section 201(a) of the CSA (21 USC 811(a)), and delegated to the Administrator of DEA by Department of Justice regulations (28 CFR 0.100), and redelegated to the Deputy Administrator pursuant to 28 CFR 0.104…“ FR 42217
  • Donnie Marshall: Notice of denial of petition to reschedule marijuana. In: Federal Register. Band 66, Nr. 75. Drug Enforcement Administration, 20. März 2001, S. 20038–20076 (Online [abgerufen am 13. Juni 2013]).

gpo.gov

  • Federal Register / Vol. 79, No. 163 / Pgs. 49661 – 49682 / 22. August 2014 DEA-Final Rule, in Kraft ab 6. Oktober 2014 Text (162 KB) PDF (242 KB)

justia.com

supreme.justia.com

justice.gov

legislink.org

  • 91. Kongress der Vereinigten Staaten: An Act to amend the Public Health Service Act and other laws to provide increased research, into, and prevention of, drug abuse and drug dependence; to provide for treatment and rehabilitation of drug abusers and drug dependent persons; and to strengthen existing law enforcement authority in the field of drug abuse. U.S. Government Publishing Office, 1970, Part F – Advisory Commission: Establishment of Commission on Marihuana and Drug Abuse, S. 1280–1281. Pub.L. 91-513, 84 Stat. 1236, erlassen am 27. Oktober 1970

nih.gov

ncbi.nlm.nih.gov

  • David T. Courtwright: The Controlled Substances Act: how a „big tent“ reform became a punitive drug law. In: Drug and Alcohol Dependence. Band 76, Nr. 1, 5. Oktober 2004, S. 9–15, doi:10.1016/j.drugalcdep.2004.04.012, PMID 15380284.
  • Paul Gee, Mark Gilbert, Sandra Richardson, Grant Moore, Sharon Paterson, Patrick Graham: Toxicity from the Recreational Use of 1-benzylpiperazine. In: Clinical Toxicology. Band 46, Nr. 9, 2008, S. 802–07, doi:10.1080/15563650802307602, PMID 18821145.
  • K. Brennan, A. Johnstone, P. Fitzmaurice, R. Lea, S. Schenk: Chronic Benzylpiperazine (BZP) Exposure Produces Behavioral Sensitization and Cross-sensitization to Methamphetamine (MA). In: Drug and Alcohol Dependence. Band 88, Nr. 2–3, 2007, S. 204–13, doi:10.1016/j.drugalcdep.2006.10.016, PMID 17125936.
  • J.H. Halpern: Hallucinogens and dissociative agents naturally growing in the United States. In: Pharmacology & Therapeutics. Band 102, Nr. 2, 2004, S. 131–138, doi:10.1016/j.pharmthera.2004.03.003, PMID 15163594.
  • David J. Nutt, Leslie A. King, Lawrence D. Phillips Independent Scientific Committee on Drugs: Drug harms in the UK: A multicriteria decision analysis. In: The Lancet. Band 376, Nr. 9752, 6. November 2010, S. 1558–1565, doi:10.1016/S0140-6736(10)61462-6, PMID 21036393.

norml.org

procon.org

marijuana.procon.org

redirecter.toolforge.org

regulations.gov

rx-wiki.org

ucsb.edu

presidency.ucsb.edu

usdoj.gov

deadiversion.usdoj.gov

web.archive.org

wikisource.org

de.wikisource.org